Nilai Dipunlarasaken Utang lan Kas Biofrontera Inc. (BFRI)

The market trend for Biofrontera Inc. (BFRI) illustrated on this price chart demonstrates an enterprise value of 15.04. Business growth is driven by Ameluz system sales in the US, the expansion of the sales department, and improved insurance coverage. Meanwhile, the company is engaged in a fierce battle with manufacturers of affordable alternatives. This dermatological player is seeking approval for the treatment of extensive skin areas while developing specialized pharmaceuticals.

BFRI (Biofrontera, Inc.) riwayat Nilai Total Perusahaan saka 23.11.2025 nganti 27.10.2026

Biofrontera (BFRI) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:

Bagan kutipan Biofrontera, Inc.|BFRI - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar Biofrontera|BFRI - Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Saham Biofrontera|BFRI - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih biofrontera-us.com|BFRI - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Biofrontera Inc.|BFRI - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Biofrontera, Inc.|BFRI - Utang perusahaan|Rasio utang marang aset resik Biofrontera

Analisis komprehensif perusahaan:Biofrontera Inc. (BFRI)

Sales of photodynamic therapy systems and the Ameluz drug across US medical centers form the asset base of Biofrontera Inc. (BFRI), the value of which is reflected in this metric. The enterprise value assessment sums the market capitalization with net debt, allowing the investor to determine the actual buyout price of the company, accounting for all liabilities and cash reserves to analyze financial stability.

Analisis pesaing Biofrontera Inc.

Krystal Biotech Inc - Nilai Wutuh Bisnis|Nilai Total Perusahaan Apogee Pharma (APGE)|ARQT - Nilai Dipunlarasaken Utang lan Kas|Vericel Corporation - Nilai Perusahaan|ORKA (orukatx.com) - Rega Tumbas Perusahaan|Nilai Total Perusahaan Sanara MedTech, Inc. SMTI|Nilai Wutuh Bisnis DBV Technologies SA|Solesence Inc (SLSN) - Nilai Perusahaan|Nilai Dipunlarasaken Utang lan Kas journeymedicalcorp.com (DERM)|Nilai Perusahaan FBRX (Forte Biosciences, Inc.)|empro.my - Nilai Perusahaan|Nilai Total Perusahaan Sol-Gel Technologies Ltd. (SLGL)|AXIL: Nilai Dipunlarasaken Utang lan Kas|MDCX (Medicus Pharma Limited) - Nilai Total Perusahaan|Verrica Pharmaceuticals Inc. (VRCA) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|HOTH (Hoth Therapeutics Inc.) - Nilai Perusahaan|Nilai Perusahaan VYNE Therapeutics Inc (VYNE)|Sonoma Pharmaceuticals (SNOA) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Dipunlarasaken Utang lan Kas QNRX (quoinpharma.com)|Nilai Total Perusahaan AZTR|Dermata Corp - Rega Tumbas Perusahaan|Elevai Labs Inc. - Nilai Total Perusahaan|RVNC - Nilai Perusahaan